Abstract:We used a murine spontaneous osteosarcoma cell line with high metastatic potential, the K7M2 cell line to study the role of Notch signaling in the biological manifestations of osteosarcoma, to understand its underlying mechanism in the regulation of cell proliferation and migration, and to improve patient prognosis in cases of osteosarcoma through the discovery of novel therapeutic targets, First, Notch expression in K7M2 was determined by immunostaining, and the γ-secretase inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) was used to inhibit proteolytic cleavage of the Notch intracellular domain (NICD), resulting in the inhibition of Notch activation. By using the Sulforhodamine B assay, colony-forming units assay, Brdu and Ki67 staining, and flow cytometry assays of apoptosis and cell cycle stage, DAPT was found to inhibit K7M2 proliferation in a dose-dependent manner. By using wound healing and transwell migration assays, DAPT was found to inhibit K7M2 migration in a dose-dependent manner as well. By using a combination of micro-Raman spectroscopy and K-means clustering analysis, we found that DAPT inhibit a variety of important cell metabolism-related components in most K7M2 cell structures. Then, DAPT was found to inhibit Notch1ICD expression in a concentration-dependent manner, and this expression was directly correlated with Phospho-Erk1/2 (p-Erk) by using Western blotting. To confirm this finding, we used the Notch signaling ligand Jagged1 to activate the Notch signaling pathway, which in turn up-regulated p-Erk, resulting in increased proliferation and migration of K7M2. Using the Erk pathway inhibitor U0126, we showed that p-Erk was downregulated and the proliferation and migration of K7M2 decreased along with it. Finally, we constructed a K7M2 mouse para-tibial tumor model and lung metastatic model. We found DAPT inhibits p-Erk in vivo, effectively controls tumor growth, reduces angiogenesis, reduces metastasis to the lungs, and improves overall survival. In summary, Notch signaling plays an oncogene role and promotes metastasis in osteosarcoma through p-Erk. DAPT effectively inhibits osteosarcoma proliferation and metastasis in vivo and in vitro by inhibiting Erk phosphorylation. Therefore, the inhibition of Notch activation resulted the down-regulation of phosphorylation of Erk pathway can be used as potential therapeutic targets in clinical treatment to improve osteosarcoma prognosis.

Non-canonical Notch Signaling Regulates Actin Remodeling in Cell Migration by Activating PI3K/AKT/Cdc42 Pathway

Down‐regulation of Notch‐1 and Jagged‐1 Inhibits Prostate Cancer Cell Growth, Migration and Invasion, and Induces Apoptosis Via Inactivation of Akt, Mtor, and NF‐κB Signaling Pathways

Notch-1 regulates collective breast cancer cell migration by controlling intercellular junction and cytoskeletal organization

Activation of MAPK signaling is associated with migration and invasion of triple-negative breast cancer cells

Death-associated protein kinase 3 modulates migration and invasion of triple-negative breast cancer cells

Notch1 is involved in migration and invasion of human breast cancer cells.

Notch Signaling Pathway Networks in Cancer Metastasis: a New Target for Cancer Therapy

Notch1 Promotes Glioma Cell Migration and Invasion by Stimulating Β‐catenin and NF‐κB Signaling Via AKT Activation

Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.

Supplementary Data from Down-Regulation of 3-Phosphoinositide–dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells

Notch Signaling Regulates Osteosarcoma Proliferation and Migration Through Erk Phosphorylation.

DOWN-REGULATION OF PDGF-D INHIBITS CELL GROWTH AND ANGIOGENESIS THROUGH INACTIVATION OF NOTCH-1 AND NF-κB SIGNALING:

Gastric Cancer Cell Growth and Epithelial-Mesenchymal Transition Are Inhibited by Γ-Secretase Inhibitor DAPT

Effect of CBX4/miR-137/Notch1 Signaling Axis on the Proliferation and Migration of Breast Cancer Cells

Notch-1 Signaling Activates NF-κB in Human Breast Carcinoma MDA-MB-231 Cells Via PP2A-dependent AKT Pathway

The Effect of Caldesmon Phosphorylation on Metastatic Tumor Cell Mobility: The Effect of Caldesmon Phosphorylation on Metastatic Tumor Cell Mobility

Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration

Type I Gamma Phosphatidylinositol Phosphate Kinase Dependent Cell Migration And Invasion Are Dispensable For Tumor Metastasis

Notch3 Inhibits Epithelial–mesenchymal Transition by Activating Kibra-mediated Hippo/YAP Signaling in Breast Cancer Epithelial Cells

Inhibition of Endothelial Cell Proliferation by Notch1 Signaling is Mediated by Repressing MAPK and PI3K/Akt Pathways and Requires MAML1

Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells